Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$5.84
-0.20-3.31%
Last update: Oct 21, 6:03 PM
$5.81
-0.23-3.78%
Kyverna Therapeutics Inc (KYTX) Stock Price, Quote, News & History
KYTXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Kyverna Therapeutics (NASDAQ:KYTX) through any online brokerage.
Other companies in Kyverna Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Kyverna Therapeutics has a consensus price target of $21.67.
The stock price for Kyverna Therapeutics (NASDAQ: KYTX) is $5.8118 last updated October 21, 2026 at 6:03 PM EDT.
There are no upcoming dividends for Kyverna Therapeutics.
Kyverna Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Kyverna Therapeutics.
Kyverna Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
